During the Miami Breast Cancer Conference, CURE discussed ADCs with Dr. Kevin Kalinsky.

The core finding: newborns who developed severe E. coli sepsis had significantly lower levels of maternally transferred anti-E. coli antibodies than matched infants who remained well. In other words, ...

COVID vaccines saved millions of lives, but months into the rollout, a small number of people began developing dangerous ...

A multi-center study led by researchers at Cincinnati Children's sheds surprising new light on why some newborns become severely ill from Escherichia coli infection, but others do not. Turns out that ...

Researchers create nanomachines using metal and polyphenols, which enhance targeted intracellular delivery of antibodies for cancer therapy. Antibodies are Y-shaped proteins produced by the body’s ...

Even with significant expansion in the global market for antibodies used in clinical care and research, scientists recognize that there is still untapped potential for finding new antibodies. Many ...

The political and scientific fight over the COVID vaccines rages on, years later, with the belated acknowledgment by the FDA ...

Prophylactic tocilizumab has the potential to decrease cytokine release syndrome and neurotoxicity for bispecific antibodies, explained Robert Rifkin, MD, a medical oncologist and hematologist with ...

Recombinant antibodies offer clear advantages over conventional polyclonal and hybridoma-derived antibodies by providing sequence-defined, renewable, and highly reproducible reagents. Their use ...

Fred Hutch Cancer Center scientists reached a crucial milestone in blocking Epstein Barr virus (EBV), a pathogen estimated to infect 95% of the global population that is linked to multiple types of ...